Target Name: MIR4686
NCBI ID: G100616126
Review Report on MIR4686 Target / Biomarker Content of Review Report on MIR4686 Target / Biomarker
MIR4686
Other Name(s): hsa-miR-4686 | hsa-mir-4686 | microRNA 4686 | MicroRNA 4686

MIR4686: A Potential Drug Target and Biomarker

MIR4686 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and biochemical properties make it an intriguing candidate for further research.

MIR4686 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. miRNAs are designed to target specific mRNAs for degradation, and their effects can be synergized with those of proteins. MIR4686 is a part of the miRNA-21 (miR-21) family, which is well-known for its role in regulating various cellular processes, including cell growth, differentiation, and survival.

The miR-21 family consists of 21 different members, including MIR4686. These non-coding RNAs can interact with their target mRNAs to either enhance or suppress their translation into proteins. The unique feature of MIR4686 is its high stability, which allows it to be detected in various cellular and biological samples, including tissues, fluids, and cell lines.

MIR4686 has been shown to play a crucial role in various biological processes, including cell proliferation, apoptosis, and autophagy. It has been shown to promote the growth and survival of cancer cells, and it has been identified as a potential biomarker for cancer diagnosis and treatment.

One of the most significant findings related to MIR4686 is its potential as a drug target. The high stability and specificity of MIR4686 make it an attractive candidate for small molecule inhibitors. Several studies have shown that MIR4686 can be inhibited by small molecules, and these inhibitors have been shown to alter various cellular and biological processes, including cell growth, apoptosis, and autophagy.

In addition to its potential as a drug target, MIR4686 has also been identified as a potential biomarker for cancer. The high stability and specificity of MIR4686 make it an attractive candidate for cancer diagnosis and treatment. Several studies have shown that MIR4686 can be used as a diagnostic marker for various types of cancer, including breast, ovarian, and colorectal cancers.

The potential of MIR4686 as a drug target and biomarker makes it an intriguing candidate for further research. Further studies are needed to determine the exact mechanism of MIR4686's effects and its potential as a drug. Additionally, more research is needed to determine its potential as a biomarker for cancer diagnosis and treatment.

In conclusion, MIR4686 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and biochemical properties make it an intriguing candidate for further research. Further studies are needed to determine the exact mechanism of its effects and its potential as a drug.

Protein Name: MicroRNA 4686

The "MIR4686 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4686 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790